Khalil Abnous Selected Research

Dextrans (Dextran)

1/2022	Fabrication of anionic dextran-coated micelles for aptamer targeted delivery of camptothecin and survivin-shRNA to colon adenocarcinoma.
1/2020	Hybrid nanoreservoirs based on dextran-capped dendritic mesoporous silica nanoparticles for CD133-targeted drug delivery.
10/2017	Synthesis and preparation of biodegradable hybrid dextran hydrogel incorporated with biodegradable curcumin nanomicelles for full thickness wound healing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Khalil Abnous Research Topics

Disease

121	Neoplasms (Cancer) 03/2024 - 02/2011
35	Breast Neoplasms (Breast Cancer) 02/2024 - 01/2015
15	Colonic Neoplasms (Colon Cancer) 01/2023 - 10/2013
12	Carcinoma (Carcinomatosis) 03/2023 - 12/2014
11	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 05/2015
11	Cardiotoxicity 01/2021 - 05/2010
9	Adenocarcinoma 07/2022 - 02/2015
8	Inflammation (Inflammations) 04/2024 - 12/2014
7	Leukemia 03/2024 - 05/2010
6	Neuroblastoma 02/2017 - 10/2015
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017 - 05/2010
5	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 01/2015
4	Neoplasm Metastasis (Metastasis) 07/2022 - 05/2017
4	Poisoning 01/2017 - 10/2012
3	Prostatic Neoplasms (Prostate Cancer) 03/2023 - 01/2020
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021 - 07/2015
3	Necrosis 01/2021 - 11/2014
3	Atherosclerosis 04/2020 - 07/2016
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 10/2013
3	Carbon Monoxide Poisoning (Poisoning, Carbon Monoxide) 01/2017 - 10/2012
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2024 - 12/2020
2	Thrombosis (Thrombus) 03/2024 - 04/2017
2	Liver Diseases (Liver Disease) 03/2024 - 02/2018
2	Epilepsy (Aura) 02/2023 - 01/2020
2	Paranoid Disorders (Paranoia) 01/2023 - 01/2022
2	Nervous System Diseases (Neurological Disorders) 02/2022 - 10/2013
2	Inborn Genetic Diseases (Disease, Hereditary) 02/2021 - 03/2016
2	Toxocariasis 01/2021 - 12/2020

Drug/Important Bio-Agent (IBA)

36	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2024 - 02/2015
30	AGRO 100IBA 03/2024 - 09/2014
21	APTIBA 03/2024 - 10/2013
20	Proteins (Proteins, Gene)FDA Link 07/2023 - 10/2013
19	NucleolinIBA 12/2023 - 09/2014
16	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 06/2013
14	Epirubicin (Ellence)FDA LinkGeneric 01/2024 - 09/2013
13	Biomarkers (Surrogate Marker)IBA 08/2022 - 02/2011
12	Peptides (Polypeptides)IBA 08/2022 - 10/2015
11	LigandsIBA 01/2024 - 06/2015
10	GoldIBA 03/2024 - 07/2015
10	Nucleotide AptamersIBA 01/2024 - 06/2015
9	Small Interfering RNA (siRNA)IBA 01/2022 - 04/2015
8	PolyethyleneimineIBA 03/2024 - 05/2015
8	Silicon Dioxide (Silica)FDA LinkGeneric 10/2023 - 06/2017
8	Adenosine Triphosphate (ATP)IBA 01/2023 - 05/2016
8	CamptothecinIBA 01/2022 - 03/2017
7	PolymersIBA 03/2024 - 03/2016
7	5TR1 aptamerIBA 01/2024 - 04/2016
6	Hyaluronic Acid (Hyaluronan)IBA 03/2024 - 12/2019
6	Epithelial Cell Adhesion MoleculeIBA 12/2021 - 02/2015
6	crocinIBA 01/2021 - 05/2013
6	Dendrimers (Dendrons)IBA 10/2018 - 04/2016
5	VaccinesIBA 07/2023 - 12/2015
5	Daunorubicin (Cerubidine)FDA LinkGeneric 03/2023 - 05/2010
5	MicellesIBA 01/2022 - 01/2018
5	AntioxidantsIBA 01/2021 - 01/2012
5	ChitosanIBA 11/2020 - 11/2014
5	Polylactic Acid-Polyglycolic Acid CopolymerIBA 03/2019 - 01/2016
4	Folic Acid (Vitamin M)FDA LinkGeneric 03/2024 - 03/2016
4	Mucin-1 (CA 15-3 Antigen)IBA 12/2023 - 04/2019
4	Nucleic AcidsIBA 08/2022 - 06/2013
4	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2022 - 11/2020
4	EnzymesIBA 09/2020 - 01/2012
4	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 09/2020 - 11/2015
4	Carbon Nanotubes (Carbon Nanotube)IBA 01/2017 - 02/2011
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2017 - 10/2012
3	BuffersIBA 02/2024 - 12/2016
3	Glycoproteins (Glycoprotein)IBA 01/2024 - 12/2018
3	CurcuminIBA 10/2023 - 10/2017
3	IntegrinsIBA 01/2023 - 10/2017
3	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 10/2017
3	Dextrans (Dextran)FDA Link 01/2022 - 10/2017
3	monomethoxypolyethyleneglycol- polylactide block copolymerIBA 12/2020 - 10/2017
3	Hematoxylin (Haematoxylon)IBA 12/2020 - 01/2013
3	Eosine Yellowish-(YS) (Eosin)IBA 12/2020 - 01/2013
3	Insulin (Novolin)FDA Link 10/2019 - 04/2016
3	liposomal doxorubicin (Doxil)FDA Link 12/2018 - 03/2016
3	polyethylene glycol-poly(lactide-co-glycolide)IBA 10/2017 - 02/2015
3	Acrolein (Aqualin)IBA 01/2015 - 01/2012
2	ResveratrolIBA 04/2024 - 12/2020
2	CollagenIBA 10/2023 - 10/2017
2	EstersIBA 09/2023 - 03/2019
2	Drug CarriersIBA 08/2023 - 01/2017
2	CarbonIBA 03/2023 - 01/2020
2	Therapeutic UsesIBA 03/2023 - 04/2015
2	Cocaine (Cocaine HCl)IBA 01/2023 - 01/2022
2	Cruciform DNA (Holliday Junctions)IBA 08/2022 - 11/2018
2	Fluorescent Dyes (Fluorescent Probes)IBA 08/2022 - 09/2019
2	PicoGreenIBA 08/2022 - 09/2019
2	SurvivinIBA 01/2022 - 11/2020
2	SMAC peptideIBA 01/2022 - 09/2020
2	SolventsIBA 12/2021 - 04/2017
2	Malathion (Karbofos)FDA LinkGeneric 01/2021 - 03/2020
2	Subunit VaccinesIBA 01/2021 - 12/2020
2	poly(lactide) (polylactic acid)IBA 09/2020 - 01/2019

Therapy/Procedure

58	Therapeutics 03/2024 - 01/2013
17	Precision Medicine 03/2024 - 03/2016
17	Drug Therapy (Chemotherapy) 03/2024 - 10/2013
6	Intravenous Injections 12/2023 - 07/2015
3	Quantum Dots (Quantum Dot) 03/2020 - 09/2014
3	Injections 10/2019 - 04/2016